|
HY-100200-10mg
|
MedChemexpress LLC
|
SMER28 [CAS 307538-42-7]
|
|
Cancer-programmed cell death
|
|
|
HY-100200-100mg
|
MedChemexpress LLC
|
SMER28 [CAS 307538-42-7]
|
|
Cancer-programmed cell death
|
|
|
HY-100200-200mg
|
MedChemexpress LLC
|
SMER28 [CAS 307538-42-7]
|
|
Cancer-programmed cell death
|
|
|
HY-100200-25mg
|
MedChemexpress LLC
|
SMER28 [CAS 307538-42-7]
|
|
Cancer-programmed cell death
|
|
|
HY-100200-5mg
|
MedChemexpress LLC
|
SMER28 [CAS 307538-42-7]
|
|
Cancer-programmed cell death
|
|
|
HY-100200-50mg
|
MedChemexpress LLC
|
SMER28 [CAS 307538-42-7]
|
|
Cancer-programmed cell death
|
|
|
HY-100374-10mg
|
MedChemexpress LLC
|
Val-Cit-PAB-MMAE [CAS 644981-35-1]
|
|
|
|
|
HY-100374-100mg
|
MedChemexpress LLC
|
Val-Cit-PAB-MMAE [CAS 644981-35-1]
|
|
|
|
|
HY-100374-5mg
|
MedChemexpress LLC
|
Val-Cit-PAB-MMAE [CAS 644981-35-1]
|
|
|
|
|
HY-100374-50mg
|
MedChemexpress LLC
|
Val-Cit-PAB-MMAE [CAS 644981-35-1]
|
|
|
|
|
HY-100383-10mg
|
MedChemexpress LLC
|
BH3I-1 [CAS 300817-68-9]
|
|
Cancer-programmed cell death
|
|
|
HY-100383-100mg
|
MedChemexpress LLC
|
BH3I-1 [CAS 300817-68-9]
|
|
Cancer-programmed cell death
|
|
|
HY-100383-25mg
|
MedChemexpress LLC
|
BH3I-1 [CAS 300817-68-9]
|
|
Cancer-programmed cell death
|
|
|
HY-100383-5mg
|
MedChemexpress LLC
|
BH3I-1 [CAS 300817-68-9]
|
|
Cancer-programmed cell death
|
|
|
HY-100383-50mg
|
MedChemexpress LLC
|
BH3I-1 [CAS 300817-68-9]
|
|
Cancer-programmed cell death
|
|
|
HY-100529-10mg
|
MedChemexpress LLC
|
PD150606 [CAS 179528-45-1]
|
|
Cancer-Kinase/protease
|
|
|
HY-100529-100mg
|
MedChemexpress LLC
|
PD150606 [CAS 179528-45-1]
|
|
Cancer-Kinase/protease
|
|
|
HY-100529-25mg
|
MedChemexpress LLC
|
PD150606 [CAS 179528-45-1]
|
|
Cancer-Kinase/protease
|
|
|
HY-100529-5mg
|
MedChemexpress LLC
|
PD150606 [CAS 179528-45-1]
|
|
Cancer-Kinase/protease
|
|
|
HY-100529-50mg
|
MedChemexpress LLC
|
PD150606 [CAS 179528-45-1]
|
|
Cancer-Kinase/protease
|
|
|
HY-10095-10mg
|
MedChemexpress LLC
|
Olcegepant [CAS 204697-65-4]
|
|
Neuroscience-Neuromodulation
|
|
|
HY-10095-2mg
|
MedChemexpress LLC
|
Olcegepant [CAS 204697-65-4]
|
|
Neuroscience-Neuromodulation
|
|
|
HY-10095-25mg
|
MedChemexpress LLC
|
Olcegepant [CAS 204697-65-4]
|
|
Neuroscience-Neuromodulation
|
|
|
HY-10095-5mg
|
MedChemexpress LLC
|
Olcegepant [CAS 204697-65-4]
|
|
Neuroscience-Neuromodulation
|
|
|
HY-10095-50mg
|
MedChemexpress LLC
|
Olcegepant [CAS 204697-65-4]
|
|
Neuroscience-Neuromodulation
|
|
